Shandong Xinhua Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CAFFEINE ANHYDROUS, with a corresponding US DMF Number 13092.
Remarkably, this DMF maintains an Active status since its submission on July 10, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 25, 2013, and payment made on February 28, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II